Preclinical Development of Therapeutics for Amyotrophic Lateral Sclerosis
Abstract
After initiating the DOD funded project TGC established relationships with Davos, Niels-Clauson-Kaas (NCK), and Metrics, for cGMP drug substance synthesis, and formulation (tablet; drug product) development, respectively. GMP API was manufactured, an HPLC assay was established and validated, and formulation development work was initiated.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2009
- Accession Number
- ADA541412
Entities
People
- Pervin Anklesaria